1)Young LR, et al:Diagnostic potential of serum VEGF-D for lymphangioleiomyomatosis. N Engl J Med 358:199-200, 2008
2)林田美江,他:特定疾患治療研究事業対象疾患.リンパ脈管筋腫症(LAM)認定基準の解説.日呼吸会誌49:67-74, 2011
3)林田美江,他:リンパ脈管筋腫症lymphangioleiomyomatosis(LAM)の治療と管理の手引き.日呼吸会誌46:428-431, 2008
4)McCormack FX, et al:Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med 364:1595-1606, 2011
5)Takada T, et al:Efficacy and safety of long-term sirolimus therapy for Asian patients with lymphangioleiomyomatosis. Ann of Am Throc Soc 13:1912-1922, 2016
6)Ando K, et al:Lung transplantation for lymphangioleiomyomatosis in Japan. PLoS One 11:e0146749, 2016